KRONOS BIO INC (KRON)
US50107A1043 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 64.33M | 76.00M | 198.30M | 248.00M | 32.60M | |||
| Marketable Securities | 108.67M | 162.20M | 141.20M | 165.10M | 59.60M | |||
| Receivables | N/A | 600.00K | 800.00K | 600.00K | 200.00K | |||
| Other Current Assets | 5.78M | 5.50M | 7.20M | 6.10M | 900.00K | |||
| Total Current Assets | 178.78M | 244.30M | 347.60M | 419.80M | 93.30M | |||
| Non-Current Assets | ||||||||
| PPE Net | 29.91M | 37.70M | 41.80M | 41.00M | 4.20M | |||
| Investments And Advances | 1.99M | 9.80M | 0.00 | 49.00M | 4.80M | |||
| Other Non-Current Assets | 2.60M | 3.20M | 2.10M | 2.20M | 400.00K | |||
| Total Non-Current Assets | 34.50M | 50.60M | 43.90M | 92.20M | 9.40M | |||
| TOTAL ASSETS | 213.28M | 294.90M | 391.50M | 512.00M | 102.70M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 13.82M | 15.30M | 11.20M | 5.90M | 1.10M | |||
| Accounts Payable | 883.00K | 5.00M | 1.00M | 4.60M | 1.50M | |||
| Other Current Liabilities | 9.99M | 1.10M | 1.50M | 2.40M | 100.00K | |||
| Total Current Liabilities | 24.70M | 21.50M | 13.60M | 12.90M | 2.70M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 29.51M | 29.00M | 32.80M | 33.60M | 300.00K | |||
| Total Non-Current Liabilities | 29.51M | 28.90M | 32.80M | 33.50M | 300.00K | |||
| TOTAL LIABILITIES | 54.20M | 50.40M | 46.40M | 46.40M | 3.00M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -508.86M | -396.20M | -263.00M | -111.90M | -23.50M | |||
| Additional Paid In Capital | 667.86M | 641.40M | 608.10M | 577.40M | 300.00K | |||
| Common Shares | 59.00K | 100.00K | 100.00K | 100.00K | 122.90M | |||
| Other Shareholders' Equity | 19.00K | -800.00K | 0.00 | 0.00 | 0.00 | |||
| Shares Outstanding | 58.95M | 57.00M | 55.70M | 54.10M | 53.00M | |||
| Tangible Book Value per Share | 2.70 | 4.29 | 6.20 | 8.60 | -0.44 | |||
| Total Shareholders' Equity | 159.08M | 244.50M | 345.10M | 465.50M | 99.70M | |||
| TOTAL LIABILITIES AND EQUITY | 213.28M | 294.90M | 391.50M | 512.00M | 102.70M | |||
| Statistics | ||||||||
| Current Ratio | 7.24 | 11.36 | 25.56 | 32.54 | 34.56 | |||
| Return On Assets (ROA) | -52.83% | -45.17% | -38.59% | -17.27% | -15.70% | |||
| Return On Equity (ROE) | -70.83% | -54.48% | -43.78% | -19.00% | -16.17% | |||
All data in USD